Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Current Drug Evaluation System 'Holds Drugs Hostage' from Patients Who May Benefit

February 8th 2018, 9:42pm

Article

Overall survival should not be the sole factor in determining whether a drug gets approved, according to Maurie Markman, M.D.

Screening Beyond Those With Cancer History May Be More Effective

February 6th 2018, 9:43pm

Article

As genetic testing becomes more accessible with advanced technology and decreased costs, population-based testing for breast and ovarian cancer may be more cost effective in the long run, according to study results published in Journal of the National Cancer Institute.

Body Mass Index Plays a Surprising Role in Immunotherapy's Effectiveness

February 6th 2018, 8:06pm

Article

“Obesity has been previously investigated for its role in cancer and promoting tumor growth, at least partially by inducing a chronic inflammatory state,” the authors wrote. “However, it’s unclear how this would play out in the era of immunotherapy, where inflammation has been linked to treatment response.”

Chemotherapy "Bath" Warms Up Chances of Ovarian Cancer Survival

February 1st 2018, 9:31pm

Article

“Adding HIPEC to interval debulking improved both recurrence free survival and overall survival without increasing morbidity,” said van Driel.

Individual Knowledge Is Power in Addressing BRCA Gene Mutations

January 29th 2018, 9:14pm

Article

As costs decrease, and physicians move to address barriers to genetic testing, a panel of physicians, researchers and a patient advocate highlighted the importance for people to get tested.

TAPUR Study Aims to Give Strength Back to Patients With Ovarian Cancer

January 25th 2018, 8:08pm

Article

Even when a patient thinks they may have exhausted their very last treatment option, the Targeted Agent and Profiling Utilization Registry (TAPUR) Study is just the thing they may need.

'Cancerversary' and Looking Back on Lessons Learned

January 17th 2018, 9:01pm

Article

Some patients refer to this as their cancerversary. With two years in the rear-view mirror, I’m calling it my Everything-From-Here-On-Out-Is-Gravy Day.

The Evolution of PARP Inhibitors in Ovarian Cancer

January 16th 2018, 2:07am

Video

Cristiana Sessa, M.D., of the Oncology Institute of Southern Switzerland, discusses the evolution of how PARP inhibitors are used to treat ovarian cancer.

Combinations May Be the Future of Immunotherapy in Ovarian Cancer

January 10th 2018, 8:00pm

Article

To date, trials testing the use of immunotherapy in the treatment of ovarian cancer yielded disappointing results. However, researchers are not giving up. Instead, they’re investigating to see if immunotherapy drugs – such as PD1 and PDL-1 inhibitors – can be combined with other agents to benefit patients.

With Cancer, Timing Is Everything

January 7th 2018, 10:16pm

Article

New discoveries happen often. Is there one for us?